BANDERA, ALESSANDRA
 Distribuzione geografica
Continente #
NA - Nord America 3.072
EU - Europa 1.765
AS - Asia 1.158
SA - Sud America 71
AF - Africa 11
Continente sconosciuto - Info sul continente non disponibili 7
OC - Oceania 5
Totale 6.089
Nazione #
US - Stati Uniti d'America 2.980
SG - Singapore 401
RU - Federazione Russa 361
HK - Hong Kong 331
CN - Cina 280
IE - Irlanda 258
DE - Germania 253
IT - Italia 248
SE - Svezia 236
UA - Ucraina 104
GB - Regno Unito 79
CA - Canada 77
BR - Brasile 62
DK - Danimarca 54
FI - Finlandia 52
FR - Francia 28
VN - Vietnam 27
ID - Indonesia 24
AT - Austria 21
TR - Turchia 21
NL - Olanda 20
IN - India 19
KR - Corea 17
BE - Belgio 13
PL - Polonia 13
IR - Iran 7
EU - Europa 5
HN - Honduras 5
JP - Giappone 5
AU - Australia 4
BZ - Belize 4
CZ - Repubblica Ceca 4
AR - Argentina 3
CH - Svizzera 3
CR - Costa Rica 3
EG - Egitto 3
ES - Italia 3
IL - Israele 3
TW - Taiwan 3
ZA - Sudafrica 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AE - Emirati Arabi Uniti 2
AL - Albania 2
AZ - Azerbaigian 2
BD - Bangladesh 2
IQ - Iraq 2
KH - Cambogia 2
LV - Lettonia 2
ML - Mali 2
MX - Messico 2
MY - Malesia 2
PT - Portogallo 2
RO - Romania 2
SA - Arabia Saudita 2
SC - Seychelles 2
UY - Uruguay 2
BG - Bulgaria 1
BS - Bahamas 1
BY - Bielorussia 1
CL - Cile 1
CO - Colombia 1
EE - Estonia 1
GR - Grecia 1
JO - Giordania 1
LK - Sri Lanka 1
LT - Lituania 1
LU - Lussemburgo 1
MA - Marocco 1
MN - Mongolia 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PE - Perù 1
PH - Filippine 1
SI - Slovenia 1
TH - Thailandia 1
VE - Venezuela 1
Totale 6.089
Città #
Ann Arbor 375
Hong Kong 328
Fairfield 276
Chandler 271
Singapore 266
Dublin 253
Woodbridge 186
Houston 185
Wilmington 169
Ashburn 163
Frankfurt am Main 163
New York 116
Seattle 101
Jacksonville 100
Dearborn 96
Cambridge 94
Milan 77
Princeton 71
Santa Clara 61
Shanghai 46
Nanjing 41
Los Angeles 38
Lawrence 32
Altamura 31
Moscow 30
Ottawa 28
Helsinki 26
Beijing 25
Fremont 21
Kent 21
Florence 19
Lachine 19
Nanchang 19
San Diego 19
Dong Ket 18
Jakarta 18
Munich 17
Buffalo 15
Seoul 14
Brussels 13
Andover 12
Edmonton 12
Hefei 12
London 12
Shenyang 12
Vienna 12
Nuremberg 11
Toronto 11
Guangzhou 10
Hebei 10
Kunming 9
Amsterdam 8
Boardman 8
Hangzhou 8
Kiev 8
São Paulo 8
Changsha 7
Falls Church 7
Jinan 7
Norwalk 7
Tianjin 7
Zhengzhou 7
Council Bluffs 6
Hanoi 6
Pune 6
Romola 6
The Dalles 6
Dallas 5
Roubaix 5
San Francisco 5
Tegucigalpa 5
Tokyo 5
Belize City 4
Bexley 4
Chicago 4
Enterprise 4
Piacenza 4
Polska 4
Rio de Janeiro 4
Taizhou 4
Turku 4
Atlanta 3
Belo Horizonte 3
Brooklyn 3
Casper 3
Clearwater 3
Columbus 3
Coventry 3
Darlington 3
Detroit 3
Düsseldorf 3
Edinburgh 3
Hyderabad 3
Kilburn 3
Melzo 3
Miami 3
Ningbo 3
Rome 3
Semarang 3
Warsaw 3
Totale 4.214
Nome #
Similar success rates but lower incidence of telaprevir-related rash in HIV/HCV coinfected as compared to HCV-monoinfected patients treated with triple anti-HCV therapy 254
Effects of autologous stem cell transplantation in HIV: searching for the origins of viral replication in settings of profound CD4(+) T cell depletion 245
Microbiota in ICU, not only a gut problem 235
Prospective immune dynamics during the first 24 weeks of efavirenz based-antiretroviral therapy in HIV-1-infected subjects, according to CD4+ T-cell counts at presentation: The IMMUNEF clinical trial 233
Triglyceride/HDL ratio and its impact on the risk of diabetes mellitus development during ART 229
Brief Report: Peripheral Monocyte/Macrophage Phenotypes Associated with the Evolution of Cognitive Performance in HIV-Infected Patients 222
A case of cerebrospinal fluid viral escape on a dual antiretroviral regimen: Worth the risk? 210
Impact of orotracheal intubation and mechanical ventilation on the microbiota of the lung in the development of Ventilator- Associated Pneumonia 204
Brachial and central blood pressure in HIV-infected subjects 201
ECMO: An alternative support for acute respiratory failure caused by tuberculosis? 194
A case of classic neuromyelitis optica (Devic's syndrome) triggered by pegylated-interferon α 193
Specific prebiotics modulate gut microbiota and immune activation in HAART-naive HIV-infected adults: Results of the "cOPA" pilot randomized trial 191
Evaluation of adhesion molecules and immune parameters in HIV-infected patients treated with an atazanavir/ritonavir- compared with a lopinavir/ritonavir-based regimen 189
Unmasking tuberculosis in the era of antiretroviral treatment 185
Lung cryptococcosis in a treated HIV-1-infected patient with suppressed viral load and past disseminated cryptococcosis: Relapse or late IRIS? 180
Strategies to limit immune-activation in HIV patients 180
Use of CXCR4-antagonist for haematopoietic stem cell mobilization in HIV-infected patients with haematological malignancies 179
Changes in subcutaneous adipose tissue microRNA expression in HIV-infected patients 179
KIR-HLA genotypes in HIV-infected patients lacking immunological recovery despite effective antiretroviral therapy 175
Combination antifungal therapy for invasive mold infections among pediatric patients with hematological malignancies: Data from a real-life case-series 160
Characterization of immune failure by monocyte activation phenotypes in HIV-infected patients receiving antiretroviral therapy 159
Under representation of the inhibitory KIR3DL1 molecule and the KIR3DL1+/BW4+ complex in HIV exposed seronegative individuals 158
High-density lipoprotein-cholesterol levels and risk of cancer in HIV-infected subjects Data from the ICONA Foundation Cohort 150
Exogenous reinfection of tuberculosis in a low-burden area 126
Plasma Proteomic Variables Related to COVID-19 Severity: An Untargeted nLC-MS/MS Investigation 123
Customization of LC-MS-based proteomic workflows for biological studies in the clinical field 116
Untargeted mass spectrometry approach to study SARS-CoV-2 proteins and characterize human plasma and saliva proteome in COVID-19 patients. 113
Plasma proteome investigation of COVID-19 patients with different outcomes through an untargeted label-free LC-MS/MS approach. 109
Impact of dexamethasone on the incidence of ventilator-associated pneumonia in mechanically ventilated COVID-19 patients: a propensity-matched cohort study 103
SARS-CoV-2 RNA in plasma samples of COVID-19 affected individuals: a cross-sectional proof-of-concept study 96
Arterial structural and functional effects of two different antiretroviral therapy protocol on naïve HIV-infected subjects 91
Immunosuppressant Treatment in Rheumatic Musculoskeletal Diseases Does Not Inhibit Elicitation of Humoral Response to SARS-CoV-2 Infection and Preserves Effector Immune Cell Populations 90
Early changes in adhesion molecules expression and endothelial function in patients initiating ART with Atazanavir or Lopinavir 89
Unmasked tuberculosis or lymphoma in late AIDS presenters: A difficult differential diagnosis 83
Prognostic Value of the Fibrosis-4 Index in Human Immunodeficiency Virus Type-1 Infected Patients Initiating Antiretroviral Therapy with or without Hepatitis C Virus 78
HIV-DNA decrease during treatment in primary HIV-1 infection with three different drug regimens: Italian Network of Acute HIV Infection (INACTION) clinical trial 77
First-line antiretroviral therapy with efavirenz plus tenofovir disiproxil fumarate/emtricitabine or rilpivirine plus tenofovir disiproxil fumarate/emtricitabine: a durability comparison 77
3-Year efficacy and durability of simplification to single tablet regimens: a comparison between co-formulated efavirenz/emtricitabine/tenofovir and rilpivirine/emtricitabine/tenofovir 76
Risk for non-AIDS-defining and AIDS-defining cancer of early versus delayed initiation of antiretroviral therapy: A multinational prospective cohort study 69
Plasma proteomic signatures related to COVID-19 disease severity by an untargeted nLC-ESI-MS/MS approach 67
Corrigendum: The Impact of Anti-rheumatic Drugs on the Seroprevalence of Anti-SARS-CoV-2 Antibodies in a Cohort of Patients With Inflammatory Arthritis: The MAINSTREAM Study(Front. Med., (2022), 9, (850858), 10.3389/fmed.2022.850858) 67
Is physician assessment of alcohol consumption useful in predicting risk of severe liver disease among people with HIV and HIV/HCV co-infection? 65
Characterization of SARS-CoV-2 proteins and human proteome in COVID-19 patients’ saliva and plasma: an untargeted mass spectrometry approach 64
Switching to dual/monotherapy determines an increase in CD8+ in HIV-infected individuals: An observational cohort study 58
Plasma, Intracellular and Lymph Node Antiretroviral Concentrations and HIV DNA Change During Primary HIV Infection: Results from the INACTION P25 Study 49
Evaluation of HIV transmission clusters among natives and foreigners living in Italy 41
Durability of different initial regimens in HIV-infected patients starting antiretroviral therapy with CD4+ counts <200 cells/mm3 and HIV-RNA >5 log10 copies/mL 39
Predictors of COVID-19 Readmission Among Patients Previously Hospitalized for SARS-CoV-2 19
Cancer incidence in people with HIV in Italy: Comparison of the ICONA COHORT with general population data 13
Occupational HIV infection in a research laboratory with unknown mode of transmission: a case report 3
Totale 6.506
Categoria #
all - tutte 26.290
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 26.290


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202022 0 0 0 0 0 0 0 0 0 0 0 22
2020/2021510 35 48 60 48 31 49 40 55 47 37 21 39
2021/2022474 15 21 46 60 20 48 21 36 23 55 29 100
2022/2023959 102 316 74 113 40 129 10 68 65 8 23 11
2023/2024754 19 14 46 32 92 217 144 37 52 23 6 72
2024/20251.800 88 181 125 90 147 78 131 38 206 318 156 242
Totale 6.506